Global Theranostics Market: Industry Analysis and Forecast (2020-2026) by Therapeutic Area, Technology and Region

Global Theranostics Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 10.5% during forecast period.

Global Theranostics Market Overview:

Theranostics is a combination of diagnosis and therapeutics, which involves nanoscience to unite diagnostic and therapeutic applications to form a single agent. The approach of Theranostics is targeted, safe and efficient pharmacotherapy. Theranostics helps in optimizing safety, effective results, and streamlining drug development. It provides a transition from conventional medicine to Theranostics.

Global Theranostics Market Dynamics:

Ongoing advances in the field of cancer therapy to overcome the side effects of conventional treatment methods will drive the theranostics market growth.

The rising prevalence of chronic diseases and the demand for innovative chemotherapeutic treatments and the need for improving disease detection are the key factors propelling the global theranostics market. In 2017, Illumina, Inc. announced the launch of the U.S. Food & Drug Administration (FDA) approved an extended RAS panel for identification of patients eligible for treatment of metastatic colorectal cancer with Vectibix (panitumumab). Reduced time for medical trials and increasing collaboration between drugs and diagnostics firms are expected to contribute to the market growth. Also, the rising use of potential and clinically adaptable nanomaterials in the biological imaging area and therapy is expected to bolster the market growth. In 2018, Biocartis Group NV and Amgen Inc. partnered to develop companion diagnostic test for Amgen's drug Veectibix. The report has profiled fourteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Global Theranostics Market Segment Analysis:

The global Theranostics Market is segmented on the basis of Therapeutic area and Technology.

Based on Therapeutic Area, the oncology segment is held largest share XX% of the global theranostics market in 2019. The segment is estimated to grow at a CAGR of 10. 3% throughout the forecast period. Owing to increasing cancer cases and theranostics potentials to make effective cancer care are the factors associated with the market growth. According to WHO (World Health Organization), in 2018, cancer is the second leading cause of death globally, and an estimated 9.6 million people died. Globally, about 1 in 6 deaths is due to cancer. Global Theranostics Market by Area To know about the Research Methodology :- Request Free Sample Report

Global Theranostics Market Regional Insights:

Global Theranostics Market by Regional

North America is expected to dominate the global market during forecast period.

Owing to the rising incidence of severe diseases like neurological disorders and cancer is the prime factor driving the market growth. According to National Cancer Institutes, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the US. Also, the availability of advanced healthcare infrastructure, strong R&D activities, and increasing collaborations are fueling the market in the region.

APAC is expected to grow at a faster pace during forecast period.

Owing to increasing awareness and adoption of companion diagnostics, especially for cancers. Global companies are also highly focusing on forming partnerships and collaborations with local players which will help in better market growth. In August 2018, Qiagen formed a collaboration with SRL Inc., a Japanese clinical lab testing company for introduction of new companion diagnostics with novel drug approvals. The report also helps in understanding Global Theranostics Market dynamics, structure by analyzing the market segments and project the Global Theranostics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Theranostics Market make the report investor’s guide.

Global Theranostics Market Scope: Inquire before buying

Global Theranostics Market by Scope

Global Theranostics Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Theranostics Market Key Players:

• F Hoffman La Roche • Thermo Fisher Scientific Inc. • GE Healthcare • Agilent Technologies • Qiagen NV • Foundation Medicine • Leica Biosystems Nussloch GmBH • Pfizer, Inc. • Beckman Coulter, Inc. • Focus Diagnostics • Illumina, Inc. • Abbott Laboratories • Myriad Genetics, Inc. • AmeriPath, Inc.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Theranostics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Theranostics Market 3.4. Geographical Snapshot of the Theranostics Market, By Manufacturer share 4. Global Theranostics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Theranostics Market 5. Supply Side and Demand Side Indicators 6. Global Theranostics Market Analysis and Forecast, 2019-2026 6.1. Global Theranostics Market Size & Y-o-Y Growth Analysis. 7. Global Theranostics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 7.1.1. Neurology 7.1.2. Cardiology 7.1.3. Oncology 7.1.4. Immunology 7.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 7.2.1. Polymerase Chain Reaction (PCR) 7.2.2. In-situ Hybridization 7.2.3. Immunohistochemistry 7.2.4. Sequencing 8. Global Theranostics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Theranostics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 9.1.1. Neurology 9.1.2. Cardiology 9.1.3. Oncology 9.1.4. Immunology 9.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 9.2.1. Polymerase Chain Reaction (PCR) 9.2.2. In-situ Hybridization 9.2.3. Immunohistochemistry 9.2.4. Sequencing 10. North America Theranostics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Theranostics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 12. Canada Theranostics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 13. Mexico Theranostics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 14. Europe Theranostics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 15. Europe Theranostics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Theranostics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 17. France Theranostics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 18. Germany Theranostics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 19. Italy Theranostics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 20. Spain Theranostics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 21. Sweden Theranostics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 22. CIS Countries Theranostics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 23. Rest of Europe Theranostics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 24. Asia Pacific Theranostics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 25. Asia Pacific Theranostics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Theranostics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 27. India Theranostics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 28. Japan Theranostics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 29. South Korea Theranostics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 30. Australia Theranostics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 31. ASEAN Theranostics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 32. Rest of Asia Pacific Theranostics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 33. Middle East Africa Theranostics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 34. Middle East Africa Theranostics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Theranostics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 36. GCC Countries Theranostics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 37. Egypt Theranostics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 38. Nigeria Theranostics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 39. Rest of ME&A Theranostics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 40. South America Theranostics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 41. South America Theranostics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Theranostics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 43. Argentina Theranostics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 44. Rest of South America Theranostics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Therapeutic Area, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Theranostics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. F Hoffman La Roche 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Thermo Fisher Scientific Inc. 45.3.3. GE Healthcare 45.3.4. Agilent Technologies 45.3.5. Qiagen NV 45.3.6. Foundation Medicine 45.3.7. Leica Biosystems Nussloch GmBH 45.3.8. Pfizer, Inc. 45.3.9. Beckman Coulter, Inc. 45.3.10. Focus Diagnostics 45.3.11. Illumina, Inc. 45.3.12. Abbott Laboratories 45.3.13. Myriad Genetics, Inc. 45.3.14. AmeriPath, Inc. 46. Primary Key Insights

About This Report

Report ID 91676
Category Healthcare
Published Date April 2021
Updated Date
Contact Us